Stryker Corporation (SYK) Shares Sold by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC lessened its stake in Stryker Corporation (NYSE:SYK) by 3.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,769 shares of the medical technology company’s stock after selling 629 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Stryker were worth $2,808,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Acrospire Investment Management LLC acquired a new position in shares of Stryker during the 2nd quarter valued at $111,000. Motco lifted its holdings in shares of Stryker by 50.7% during the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after acquiring an additional 278 shares in the last quarter. San Francisco Sentry Investment Group CA lifted its holdings in shares of Stryker by 47.8% during the 3rd quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock valued at $143,000 after acquiring an additional 325 shares in the last quarter. Bruderman Asset Management LLC acquired a new position in shares of Stryker during the 2nd quarter valued at $150,000. Finally, James Investment Research Inc. acquired a new position in shares of Stryker during the 2nd quarter valued at $155,000. Institutional investors own 74.97% of the company’s stock.
Several equities analysts recently weighed in on the stock. Cowen set a $166.00 target price on shares of Stryker and gave the company a “buy” rating in a report on Sunday, October 29th. Needham & Company LLC restated a “hold” rating on shares of Stryker in a report on Friday, November 3rd. ValuEngine lowered shares of Stryker from a “buy” rating to a “hold” rating in a report on Friday, December 1st. SunTrust Banks reaffirmed a “buy” rating and set a $161.00 price target on shares of Stryker in a research note on Friday, November 17th. Finally, Oppenheimer set a $156.00 price target on shares of Stryker and gave the stock a “hold” rating in a research note on Monday, October 30th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have assigned a buy rating to the company. Stryker has a consensus rating of “Hold” and a consensus price target of $153.19.
Shares of Stryker Corporation (NYSE:SYK) opened at $154.25 on Friday. The stock has a market cap of $57,726.21, a price-to-earnings ratio of 24.45, a P/E/G ratio of 2.43 and a beta of 0.78. Stryker Corporation has a one year low of $116.50 and a one year high of $160.62. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63.
Stryker (NYSE:SYK) last released its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.39 EPS. analysts expect that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be given a $0.47 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.88 annualized dividend and a dividend yield of 1.22%. This is an increase from Stryker’s previous quarterly dividend of $0.43. Stryker’s payout ratio is presently 36.32%.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Stock Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related stocks with our FREE daily email newsletter.